NCT01996215

Brief Summary

This study is to determine how cognitive deficits (e.g.,verbal fluency deficit) in patients with Age-Related Macular Degeneration (AMD) relate to specific aspects of brain and function. The study team will assess whether the "brain signatures" associated with specific cognitive deficits differ in older adults with and without AMD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
238

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 27, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

February 7, 2019

Status Verified

December 1, 2018

Enrollment Period

4.2 years

First QC Date

November 22, 2013

Last Update Submit

February 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cognitive Changes and Brain Connectivity in Age-Related Macular Degeneration

    All Participants will receive neurocognitive testing, health and lifestyle surveys, audiometry and eye exams. Brain MRIs will be obtained on half the cohort, as this will provide sufficient power to accomplish the Aims that involve neuroimaging data. These MRIs will be obtained while participants are in the "resting state" meaning they are awake but not instructed to perform specific scanner. Two years after baseline exams, participants will return for repeat data collection. Participants who received an MRI at baseline will receive repeat resting-state, brain MRI at 2-year follow-up, unless they have developed contradictions to MRI scans in the interim.

    Baseline, anticipated 2 years

Study Arms (2)

AMD controls

AMD cases

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will include 300 participants: 150 subjects with AMD plus 150 age, gender, and education-matched adults without AMD. All participants will receive baseline and 2 year neurocognitive tests and a subset will provide structural and "resting stage"functional magnetic resonance images (MRIs) at each time point.

You may qualify if:

  • AMD
  • \- Vision loss attributable to AMD
  • Controls
  • Age match (± 5 yrs)
  • Gender match
  • Education match (± 4yrs)
  • Normal macular exam

You may not qualify if:

  • AMD
  • Other significant eye pathology
  • Mod/severe dementia
  • Communication barrier that precludes testing
  • Controls
  • Other significant eye pathology
  • Mod/severe dementia
  • Communication barrier that precludes testing
  • MRI subset
  • Devices or material incompatible with 3.0 Tesla MRI
  • Conditions that may interfere with interpretation of fMRI (e.g. history of stroke, brain tumor or previous brain surgery; psychoactive medications; seizure disorder)
  • Claustrophobia
  • Left-handed
  • Body weight \> 300 lbs
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Officials

  • Heather Whitson, MD

    Duke Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2013

First Posted

November 27, 2013

Study Start

April 1, 2014

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

February 7, 2019

Record last verified: 2018-12

Locations